Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918779 | Radiotherapy and Oncology | 2013 | 8 Pages |
Abstract
In selected patients of locally advanced oropharyngeal cancer, concomitant boost offers a better compliance, toxicity profile and quality of life with similar disease control, than chemoradiation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anupam Rishi, Sushmita Ghoshal, Roshan Verma, Arun S. Oinam, Vijai M. Patil, Rakesh Mohinder, Suresh C. Sharma,